PATENT CLAIM ANALYSIS

Application Number: 15762878
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "210180"]

Abstract:
The present invention relates to a compound with formula (I) or a salt and/or a pharmaceutically acceptable solvate thereof, the method for preparing same as well as the uses thereof, in particular the therapeutic use thereof, mainly in the treatment of diseases associated with a hyperactivity of the endocannabinoid system.

Claim (Index 4):
The compound according to  claim 1 , wherein R 1  is a hydrogen atom and R 2  represents a COR 3 , SO 2 R 4  or CONR 5 R 6  group, with R 3 , R 4 , R 5  and R 6  being as defined in  claim 1 .

Metadata:
- Claim Count in Document: 41.0
- Percentile: 90.0
- Lexical Diversity: 1.36585
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14370951', '14555290', '15771077', '14679846', '15263033']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7517178301236225
- 35 USC 102 Novelty (BERT): 0.5099875068043132
- Combined Prediction Score: 0.7275447977916916
- Mean Citation Score: 269.005014
- Max Citation Score: 274.28796
- Similarity Product: 218.9059986903692

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test